Esaote won a major contract in Italy in March. Under a partnership with WDM, Esaote expands its range and boosts its capacity to respond to the demands of the international market.

From 15 to 19 July, Esaote will take part in the Virtual Expo with a booth space where visitors can discover the latest ultrasound, dedicated MRI and healthcare IT technologies.

First, Esaote came to the aid of China, a country with which the company has strong connections, given that their shares are owned by a group of six Chinese industrial (Wandong, Yuwell, Kangda) and financial companies (Yunfeng, Shanghai Ftz, Tianyi).

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

We have a duty to develop a complete understanding of the limits within which we can carry out our production activities. Today, it is within those limits that we can grow and do more.

In these days we are facing two epidemic events. The first one is the new coronavirus that is putting many countries in the world in great difficulty.

Rome, February 14th, 2020 - Esaote, an Italian company among the world leaders in the field of medical diagnostic imaging systems, is the Ducati Team's Official Partner for the 2020 season. The collaboration agreement between the two brands was...

Genoa, February 6th 2020 - BNP Paribas Leasing Solutions, European leader in asset finance, and Esaote, one of the world's leading manufacturers of medical diagnostic systems, announced today the signature of an international partnership.

Franco Fontana new CEO, Eugenio Biglieri new Chief Operating Officer. A new Board of Directors has been appointed.

Genoa, 13 May 2019 - The Shareholder’s Meeting of Esaote S.p.A. – a leading Company in the sector of diagnostic imaging - held in...

March 26th - Genoa, Italy – “Never Stop Seeing the Unseen": this is the title of the new communications campaign of Esaote, an Italian company among the world leaders in diagnostic imaging, which for over thirty years has been designing, creating and...

FAST study demonstrates high diagnostic accuracy of CAAS vFFR and received USA 510(k) market clearance.

Esaote SpA announces the completion of the acquisition of its share capital by a Consortium of leading Chinese investors.

New investor is a consortium of leading chinese healthcare companies and financial sponsors.

26th August 2017 [Barcelona, Spain] ‐ Esaote has the pleasure to support the ESC 2017, European Cardiovascular Congress (Barcelona, Spain ‐ August 26th‐30th)

Esaote presents his experience on the Chinese market in the meeting organized by the Liguria Region with a delegation from Guangdong.

Ebit (Esaote Group) and Siemens Healthineers signed an important partnership to resell Suitestensa, the Ebit software dedicated to cardiology

Today Esaote S.p.A. (www.esaote.com) opened a new plant for the company’s research and production of dedicated MRI systems in Genoa Multedo

At the historical headquarter in Via di Caciolle, Florence – Esaote S.p.A., leader in the biomedical electronics sector, inaugurated its new Centre of Excellence for Probes

North Wales Glan Clwyd Hospital is the first NHS Hospital to invest in a weight-bearing MRI scanner...

30th October 2014, [GENOA, ITALY] - Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab^™Gamma, a best in class, highly-portable “green” ultrasound system at WINFOCUS Congress...

28 October 2014 [Genoa, Italy] - Esaote, the world’s number one veterinary imaging ultrasound and MRI announces its 7th MRI Symposium...

28th October 2014 [Genoa, Italy] - At MEDICA 2014 (World Forum for Medicine - Düsseldorf, Germany – 12-15 Nov 2014) ESAOTE will showcase two new ultrasound machines, confirming its position as a leading innovator in the global ultrasound imaging...

7th October 2014 [Genoa, Italy] - At JFR 2014 (Journées Francaises de Radiologie - Paris, France) ESAOTE will showcase two new ultrasound machines, confirming its position as a leading innovator in the global ultrasound imaging market, delivering...

Genoa, Italy 25th August 2014 - Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab^™Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC...

Genoa, Italy 25th August 2014 - Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab^™Gamma, a best in class, highly portable “green” ultrasound system at ESC Congress...

Genoa, Italy 06th August 2014 - Esaote introduces Evolution, the latest version of its continuous improvement program...

Genoa, Italy 18th July 2014 - Esaote announces the launch of two new ultrasound machines, confirming its position as a leading innovator in the global ultrasound imaging market...

Buenos Aires, Argentina, June 17th 2014 – Accurate MSK diagnosis directly at the playing field with the Esaote O-scan Dedicated MRI and MyLab^™ClassC Ultrasound...

Genoa, Italy, April 16th 2014 – At the 44th São Paulo Radiological Meeting, Esaote launches CrystaLine, a significant evolution of its ultrasound technology...

Washington DC, March 28, 2014 – At the 63rd Annual Scientific Session of the American College of Cardiology, Esaote is demonstrating new CrystaLine imaging technology...

Esaote's QIMT uses radio frequency to measure intima-media thickness, conferring early diagnosis, improved quality of life and cost reduction.

On the occasion of Medica, the world’s largest event for the medical sector, to be held in Düsseldorf on November 20th-23rd, Esaote presents eHD Technology and Prevention Suite.

ECHOLASER, the first and unique integrated system dedicated to ultrasound diagnosis and therapy for laser thermoablation, has been adopted by the American Hospital of Paris for the treatment of benign thyroid nodules.

Royal Preston Hospital, part of the Lancashire Teaching Hospitals NHS Foundation Trust, has invested in Esaote's O-Scan - a compact MRI unit for extremities scanning.